Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CHYR TONG DAN SOLUTION is an over-the-counter (OTC) multi-symptom cold and flu medication manufactured by Min Tong Chemical Pharmaceutical in Taiwan. Despite the manufacturer's association with traditional Chinese medicine, this product is a conventional small molecule pharmaceutical combination. It contains acetaminophen (paracetamol) for pain and fever relief, chlorpheniramine maleate as an antihistamine to reduce runny nose and sneezing, DL-methylephedrine hydrochloride as a decongestant and bronchodilator, and caffeine anhydrous to counteract drowsiness and enhance analgesic effects. It is indicated for the symptomatic relief of the common cold and influenza, including fever, headache, muscle aches, nasal congestion, and cough.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CHYR TONG DAN SOLUTION.